Apotheca Biosciences, Inc. (CBDC) financial statements (2020 and earlier)

Company profile

Business Address 10901 ROOSEVELT BLVD.,
SAINT PETERSBURG, FL 33716
State of Incorp. NV
Fiscal Year End January 31
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3 03
Cash and cash equivalents3 03
Inventory, net of allowances, customer advances and progress billings8   
Inventory8   
Prepaid expense6   
Deposits current assets6   
Other undisclosed current assets86   
Total current assets:109 03
Noncurrent Assets
Property, plant and equipment6   
Total noncurrent assets:6   
TOTAL ASSETS:115 03
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1071851
Accounts payable24   
Accrued liabilities83   
Other undisclosed accounts payable and accrued liabilities 1851
Debt19157  
Due to related parties8472928
Total current liabilities:1342223329
Noncurrent Liabilities
Other undisclosed liabilities798   
Total liabilities:9322223329
Stockholders' equity
Stockholders' equity attributable to parent, including:(817)(222)(33)(26)
Common stock11850  
Additional paid in capital1,504173827
Accumulated deficit(2,512)(290)(79)(61)
Other undisclosed stockholders' equity attributable to parent74 88
Total stockholders' equity:(817)(222)(33)(26)
TOTAL LIABILITIES AND EQUITY:115 03

Income statement (P&L) ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
Gross profit: (62)  
Operating expenses(2,276)(188)(15)(34)
Other undisclosed operating income 62  
Operating loss:(2,276)(188)(15)(34)
Nonoperating expense(236)(8)  
Loss before gain (loss) on sale of properties:(2,512)(196)(15)(34)
Other undisclosed net loss  (3)(5)
Net loss available to common stockholders, diluted:(2,512)(196)(18)(39)

Comprehensive Income ($ in thousands)

1/31/2019
1/31/2018
1/31/2017
1/31/2016
Net loss:(2,512)(196)(18)(39)
Comprehensive loss, net of tax, attributable to parent:(2,512)(196)(18)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: